Steric aspects of adrenergic drugs. XXII. Retention of (+)- and (-)- 14 C-norepinephrine by mouse heart.
D000818:Animals; D002247:Carbon Isotopes; D002394:Catechol O-Methyltransferase / Q000378:metabolism; D006145:Guanethidine / Q000494:pharmacology; D006892:Hydroxydopamines / Q000494:pharmacology; D066298:In Vitro Techniques; D007490:Iproniazid / Q000494:pharmacology; D007536:Isomerism; D008297:Male; D008745:Methylation; D008781:Methyltyrosines / Q000494:pharmacology; D051379:Mice; D008813:Mice, Inbred ICR; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009206:Myocardium / Q000201:enzymology / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism*; D012110:Reserpine / Q000494:pharmacology; D013997:Time Factors; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors
D002247:Carbon Isotopes; D006892:Hydroxydopamines; D008781:Methyltyrosines; D008996:Monoamine Oxidase Inhibitors; D012110:Reserpine; D007490:Iproniazid; D014446:Tyrosine 3-Monooxygenase; D002394:Catechol O-Methyltransferase; D009638:Norepinephrine; D006145:Guanethidine